Lys-lys

Lysyllysine is a dipeptide composed of two lysine residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived in

Amyloid β-Protein (36-42), the 36-42 fragment of β-Amyloid, consists of a polypeptide chain of 36-43 amino acids and is a primary constituent of amyloid plaques in Alzheimer's disease (AD) patients' brains. β-Amyloid oligomers (Aβos) critically contribute to AD progression by causing neuronal harm and cognitive decline [1].

Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly is a 13-mer synthetic peptide with a sequence homologous to seven amino acids of the SV40 T antigen, recognized for its ability to induce nuclear transport [1].

Lys-arg-ala-lys-ala-lys-thr-thr-lys-lys-arg is a protein kinase C substrate.

H-Lys(Tfa)-OH is an inhibitor of L-lysine cyclodeaminase.

Fmoc-Lys-OH hydrochloride is an alkyl-chain-based PROTAC linker and a non-cleavable ADC linker utilized in the synthesis of antibody-drug conjugates (ADCs).

Fmoc-Lys-OH (Nα-Fmoc-L-lysine) is a lysine derivative commonly utilized in the synthesis of active compounds.

Z-Lys-OH is a competitive inhibitor of papain, a lysine derivative.

Boc-Lys(Boc)-OH is an amino acid derivative used in peptide synthesis, where the α-amino and ε-amino groups of lysine are protected by Boc groups.

Fmoc-Lys(Tfa)-OH is a peptide, a lysine derivative with an Fmoc protective group on the α-amino group, widely used in biochemical experiments and drug synthesis research.

H-DL-Lys-OH HCl is the hydrochloride salt of lysine, widely used in biochemical experiments and drug synthesis research.

Fmoc-Lys(Boc)-OH (N-α-(Fmoc)-N-ε-(t-boc)-L-Lysine-OH) is a lysine derivative that acts as a reactive linker.

Fmoc-Lys(Z)-OH is a lysine derivative with an Fmoc protecting group, widely used in biochemical experiments and drug synthesis research.

Fmoc-Lys(Alloc)-OH is a lysine derivative containing Fmoc protecting group, which can be used for peptide synthesis and drug design.

Lys-[Des-Arg9]Bradykinin acetate is an endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.

N-ε-propargyloxycarbonyl-L-lysine hydrochloride (N6-((Prop-2-yn-1-yloxy)carbonyl)-L-lysine hydrochloride) is a modified amino acid for cancer therapy development.

N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide that acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM for FPR1, 6.7 μM for FPR2, and 0.88 μM for FPR2-D2817.32G. This chemotactic peptide binds specifically to receptors on leukocyte membranes and its uptake can contribute to the quantitative assessment of neutrophils in localized inflammatory processes, independent of associated edema formation or microcirculatory compromise.

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). It contains the microtubule polymerization inhibitor DM1 as the active metabolite, which inhibits microtubule polymerization. It is commonly used in breast cancer research.

Fmoc-Lys (biotin-PEG4)-OH is a biotinylated and PEG-modified linker used for PROTAC synthesis [1].

H-Lys-Trp-Lys-OH, a small molecule peptide, exhibits both antibacterial and antiviral activities.

H-Lys-Trp-Lys-OH acetate is a peptide with antibacterial and antiviral activities.

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs), innovative therapeutic agents that combine the targeting ability of antibodies with potent cytotoxic drugs.

Boc-Phe-(Alloc)Lys-PAB-PNP serves as a cleavable linker in the synthesis of antibody-drug conjugates (ADCs).

Cbz-Phe-(Alloc)Lys-PAB-PNP, a cleavable linker, is utilized in the design of antibody-drug conjugates (ADCs).